Business News
Home > Business News
RIL arm acquires stake in Strand Life Sciences for Rs 393 cr
TIWN
TIWN
PHOTO : TIWN
Mumbai, Sep 3 (TIWN) Reliance Strategic Business Ventures Limited (RSBVL), a wholly-owned subsidiary of Reliance Industries (RIL), has acquired over 2.28 crore equity shares stake in Strand Life Sciences Pvt Ltd for Rs 393 crore.
A further investment of up to Rs 160 crore is expected to be completed by March 2023, it said. The total investment will translate into 80.3 per cent of equity share capital in Strand on a fully-diluted basis. Incorporated in India on October 6, 2000, Strand is a pioneer of genomic testing in the country with bioinformatics software and clinical research solutions to healthcare providers including clinicians, hospitals, medical devices manufacturers and pharmaceutical companies.
Add your Comment
Comments (0)
More Business News
- Indian tech leaders stand behind Ola's Bhavish in his fight against Microsoft & LinkedIn
- How volatility hit the Indian markets in last three elections
- Dell discloses data breach of some customers’ names, physical addresses
- India on the cusp of becoming a global tech powerhouse: Industry leaders
- Air India Express row: 85 flights cancelled as cabin crew members continue strike